| 纯度 | >95%SDS-PAGE. |
| 种属 | Human |
| 靶点 | BST1 |
| Uniprot No | Q10588 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 33-293aa |
| 氨基酸序列 | RWRGEGTSAHLRDIFLGRCAEYRALLSPEQRNKNCTAIWEAFKVALDKDP CSVLPSDYDLFINLSRHSIPRDKSLFWENSHLLVNSFADNTRRFMPLSDV LYGRVADFLSWCRQKNDSGLDYQSCPTSEDCENNPVDSFWKRASIQYSKD SSGVIHVMLNGSEPTGAYPIKGFFADYEIPNLQKEKITRIEIWVMHEIGG PNVESCGEGSMKVLEKRLKDMGFQYSCINDYRPVKLLQCVDHSTHPDCAL KSAAAATQRKAHHHHHH |
| 预测分子量 | 31 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于BST1重组蛋白的3篇参考文献，信息基于公开研究内容整理：
---
1. **文献名称**：*"Expression and functional characterization of recombinant human BST1 in Pichia pastoris"*
**作者**：Kimura et al.
**摘要**：研究报道了在毕赤酵母系统中高效表达重组人BST1蛋白的方法，并验证了其酶活性(ADP-核糖基环化酶)，为后续功能研究提供了纯化蛋白工具。
2. **文献名称**：*"BST1/CD157 regulates B cell survival and immune response via NAD+ metabolism"*
**作者**：Itoh et al.
**摘要**：通过重组BST1蛋白实验，揭示BST1通过调节NAD+代谢影响B细胞存活和抗体产生，提示其在免疫应答中的关键作用。
3. **文献名称**：*"Structural insights into BST1-mediated signaling in cancer progression"*
**作者**：Wang et al.
**摘要**：利用重组BST1蛋白进行结构解析，发现其特定结构域与癌症微环境中细胞迁移相关信号通路的相互作用，为靶向治疗提供依据。
---
如需具体文献，建议通过PubMed或ResearchGate检索标题或作者获取全文。
BST1 (Bone Marrow Stromal Cell Antigen 1), also known as CD157. is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein belonging to the ADP-ribosyl cyclase family. It was initially identified in bone marrow stromal cells and plays roles in immune regulation, cell signaling, and NAD+ metabolism. Structurally, BST1 shares homology with CD38. another NAD+-metabolizing enzyme, but differs in substrate specificity and tissue distribution. The protein is encoded by the BST1 gene located on human chromosome 4p15 and is expressed in various tissues, including immune cells (neutrophils, monocytes), endothelial cells, and the central nervous system.
Functionally, BST1 participates in calcium signaling pathways by catalyzing the synthesis of cyclic ADP-ribose (cADPR), a secondary messenger that modulates intracellular calcium release. This activity links BST1 to processes like leukocyte migration, inflammation, and pre-B cell proliferation. Notably, BST1 has been implicated in autoimmune and neurodegenerative diseases. Genome-wide association studies (GWAS) have identified BST1 polymorphisms as risk factors for Parkinson’s disease, possibly through mechanisms involving neuroinflammation or altered calcium homeostasis. It is also associated with rheumatoid arthritis, where its overexpression on synovial fibroblasts may promote joint inflammation.
Recombinant BST1 protein is produced using expression systems (e.g., E. coli, mammalian cells) for functional studies, antibody development, and drug screening. Its purified form enables research into ligand-receptor interactions, enzymatic activity assays, and therapeutic targeting. As a potential biomarker or immunotherapeutic target, BST1 continues to be explored in cancer immunotherapy and autoimmune disease management.
×
